Welcome to our January/February 2022 Newsletter!
Watch for a new mini edition each month...
View this email in your browser

In This Issue

  • COVID-19 Update
  • NSIV New Members
  • Keeping up with NSIV
  • Keeping up with NSIV Graduates
  • What's going on

NSIV Website

Find all these stories and more on our website! Stay informed at

Keep Up With Us

LinkedIn LinkedIn
Twitter Twitter
Facebook Facebook
YouTube YouTube
COVID-19 Update

As of Monday, February 7, NSIV will be returning to the COVID policies in place before January 2022.

Face Coverings are required for:

     o   Non-vaccinated individuals

     o   Vaccinated and boosted individuals, or individuals who have had                    COVID in the past 90 days, all of whom are monitoring for symptoms            after an exposure and who are not required to stay at home

     o   Any one working with COVID in NSIV labs.

Face Coverings are optional for everyone else.

Electronic sign-in will not be required.

NSIV Staff will return to its normal schedule

Visitors are allowed, but they must sign in.

NSIV New Members
BioLumic UV technology delivers ultra-violet light to seeds and seedlings to trigger biological mechanisms that increase plant growth, vigour, and yields. BioLumic LTD plans to establish a science function to provide US-based diagnostic marker processing and development in multiple crop targets, in addition to an operational hub for expanding commercial demand for Cannabis Light Recipe deployments. This next phase will see continuing expansion of BioLumic’s platform technology for yield, compositional, and crop protection gains in major row crops and controlled environment crops.
TurtleTree uses modern cell-based technology to create sustainable food products that are better for the planet, better for the animals, and better for human consumption.  The Signapore start-up expects to launch its first products in the U.S. soon using its cell-based dairy ingredients through multiple B2B partnerships and fully commercialize its cultured milk within the next four to five years.

Keeping Up with NSIV
Genomic Expression has developed a RNA platform for next-generation cures called OneRNA®. By analyzing RNA they can detect disease, monitor health and design next-generation cures. During the pandemic they validated their own COVID-19 PCR test  securing supply chain and filed a FDA EUA. They entered into a collaboration with Yale enabling COVID-19 in a self-collected saliva sample making testing easier and faster. This was followed by another invention that enabled massive scaling of testing using sequencing instead of PCR which landed them in the semifinals of the XPRIZE. 

Since May of 2020, they have processed over 10,000 tests. They have also employed seven interns sponsored by the MA Life Science Center. Recently, they have purchased two new pieces of equipment, and, to expand throughput.

Today they provide effective COVID-19 testing for schools, corporations, MA Taskforce/FEMA and local towns as well as several touring rock bands.  
Keeping Up With NSIV Graduates
Nth Cycle raised $12.5 million in Series A financing to help it deploy its environmentally friendly critical minerals recovery technology commercially.  The funding was co-led by the investment arm of Frankstahl, one of the largest privately held steel distribution companies in Europe, and VoLo Earth, a Colorado-based venture firm focused on climate solutions.  Nth Cycle developed a process called electro-extraction to recover critical minerals such as cobalt and nickel using electricity and carbon filters.  
What's Going On?

Registration is open for MassBio’s annual State of Possible on May 5 at the Royal Sonesta in Cambridge. Join us as we celebrate how the life sciences make the impossible possible and discuss the Massachusetts biopharma ecosystem in the post-COVID era.

Early bird pricing is now in effect for just a short time. Reserve your spot at our biggest event of the year as we tap into the brightest minds in the industry. Review the agenda and register today.

VIRTUAL CAREER FAIR March 4, 2022 | 3:00 pm - 5:00 pm | Zoom Meeting

Kickstart your life sciences career at this FREE event!

Register Now
Copyright © 2021 North Shore InnoVentures, All rights reserved. 
You are receiving our newsletter because you have indicated that you wished to receive updates on NSIV events and news. Please let us know how we can best keep you up to date! 
Our mailing address is: 
North Shore InnoVentures
100 Cummings Center
Suite 451C
Beverly, MA 01915
Add us to your address book
Email Marketing Powered by MailChimp
 unsubscribe from this list | update subscription preferences 

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
North Shore InnoVentures · 100 Cummings Center · Suite 451C · Beverly, MA 01915 · USA

Email Marketing Powered by Mailchimp